USU Researchers to Support NIAID in US-Liberia Ebola Clinical Trial Partnership

A new clinical trial to obtain safety and efficacy data on the investigational drug, ZMapp, as a treatment for the Ebola virus, was launched today by the National Institute of Allergy and Infectious Diseases (NIAID), in partnership with the Liberian government. Scientists from the Uniformed Services University of the Health Sciences (USU) will play a role in the evaluation.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews